Company reports US$522K in July sales, US$403K in August sales, and US$2.07M in sales for the first eight months of 2026, ...
InMed Pharmaceuticals Receives Nasdaq Notification Regarding Minimum Shareholders’ Equity Compliance
September 18, 2026) - InMed Pharmaceuticals Inc. (NASDAQ: INM) ("InMed" or the "Company"), a pharmaceutical company focused ...
MINNEAPOLIS, MN – September 16, 2026 – Evia Bio, Inc., a life science company advancing next-generation cryopreservation ...
Electra Therapeutics has exceeded its initial fundraising plans as it becomes the 26th biotech to debut publicly this year and outlines pivotal development plans for its monoclonal antibody ...
Discover innovative financial strategies and expert guidance from leading bioscience finance executives at this first-ever ...
A new five-year biotech plan has been released by the Chinese government, revealing ambitious goals such as achieving five blockbuster medicines on the global markets in that time.
Takeda (TSE:4502/NYSE: TAK) announced that it has awarded a total of USD 22.2 million to four new Global Corporate Social ...
As part of its Regenerative Neurology Program, Longevity Medical Institute® is making MUSE cell therapy available to select ...
The U.S. Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) for dersimelagon for filing and ...
Zealand Pharma receives positive CHMP opinion for Zeydovio™ (glepaglutide) for the treatment of short bowel syndrome The CHMP ...
Connection details for the SENS-601 Program Day are as follows: Date and time: September 22, 2026, at 2:30pm CET (8:30am ET) ...
PARIS, FRANCE, 18 SEPTEMBER 2026 - Ipsen (Euronext: IPN; ADR: IPSEY) announced today the co-optation of Mariette Finet as a ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results